Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer.
Zalazar F, Luca P, Gardner K, Figg WD, Meiss R, Spallanzani RG, Vallecorsa P, Elguero B, Cotignola J, Vazquez E, Siervi A.
Zalazar F, et al. Among authors: gardner k.
Curr Pharm Biotechnol. 2019;20(12):1072. doi: 10.2174/138920102012190919103433.
Curr Pharm Biotechnol. 2019.
PMID: 31701844
Due to some inconsistencies in the figures provided by the first author that have come to light, and after a thorough investigation we would like to retract our paper: "Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer. By: Zalaza …
Due to some inconsistencies in the figures provided by the first author that have come to light, and after a thorough investigation we would …